arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Dominari Holdings Inc.

DOMH Health Care Biotechnology: Pharmaceutical Preparations
$2.12
▲ +0.9% Today
as of Sep 4, 16:48 ET
Last 30 days -15.32% Jul 27 → Sep 04
$2.02 $2.32 $2.62 $2.92 $3.22 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$2.15
High
$2.16
Low
$2.09
Volume
$150,220
Avg Vol
$194,378
Mkt Cap
$63M
P/E (TTM)
0.58
Beta
—
52w High
$8.40
52w Low
$2.09
Div Yield
—
Shares Out
$24M

Recent Press Releases & News last 60 days · 2 items

Aug 11 · 12:00 PR PR Newswire
Dominari Year to Date Revenue Increases by 14% Over 2025
Aug 3 · 12:30 PR PR Newswire
Dominari Congratulates Powerus on its Multimillion Dollar Contract for Aerial Drone System

Overview

52-week range
$2.09
$8.40
0% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
+0.9%
50% positive
Latest IV / EM
76%
EM ±11.9% · $2 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-3.17$-0.56$2.05$4.66$7.27 Actual $-0.71Actual $-1.79Actual $-0.66Actual $-0.91Actual $-1.01Actual $-0.67Actual $-3.02Actual $-1.02Actual $7.27Actual $-3.17 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026
Revenue vs Net Income Revenue Net income
$-57M$-10M$37M$84M$131M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-3.17 — — -5.0% +3.7% earnings
Tue Sep 30, 2025Sep 2025 $7.27 — — — — financials
Mon Aug 11, 2025Jun/2025 $-1.02 — — — — earnings
Mon May 12, 2025Mar/2025 $-3.02 — — — -2.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.67 — — — — financials
Sun Jun 30, 2024Jun 2024 $-1.01 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.91 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.66 — — — — financials
Fri Jun 30, 2023Jun 2023 $-1.79 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.71 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$17M$36M—$51M$39M$7M—$4M
Cost of revenue————————
Gross profit————————
Operating income$-1M$-38M—$-2M$-15M$-33M—$-3M
Net income$-5M$-57M—$125M$17M$-32M—$-4M
EPS (diluted)—$-3.17—$7.27$1.12$-3.02—$-0.67

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$25M$27M$34M$5M$9M$6M$4M$3M
Inventory————————
Total current assets———$206M$60M$35M$28M$25M
Total assets$57M$85M$113M$223M$109M$52M$47M$43M
Long-term debt————————
Total liabilities$36M$54M$44M$13M$21M$10M$7M$5M
Total equity$22M$32M$69M$210M$89M$42M$40M$38M

Implied volatility — last 90 days

47%615%1183%1750%2318% Jun 07 — IV 378% · EM ±52.4%Jun 08 — IV 400% · EM ±52.8%Jun 09 — IV 724% · EM ±90.8%Jun 10 — IV 841% · EM ±99.4%Jun 11 — IV 863% · EM ±95.3%Jun 12 — IV 959% · EM ±98.1%Jun 15 — IV 912% · EM ±66.0%Jun 16 — IV 1190% · EM ±70.3%Jun 17 — IV 2318% · EM ±96.8%Jun 19 — IV 275% · EM ±60.8%Jun 22 — IV 287% · EM ±59.9%Jun 23 — IV 363% · EM ±74.3%Jun 24 — IV 261% · EM ±52.3%Jun 25 — IV 317% · EM ±62.1%Jun 29 — IV 307% · EM ±54.3%Jun 30 — IV 435% · EM ±74.8%Jul 01 — IV 432% · EM ±72.1%Jul 02 — IV 305% · EM ±49.3%Jul 03 — IV 316% · EM ±49.3%Jul 06 — IV 394% · EM ±54.6%Jul 07 — IV 379% · EM ±50.0%Jul 08 — IV 336% · EM ±42.1%Jul 09 — IV 423% · EM ±50.0%Jul 10 — IV 240% · EM ±26.5%Jul 13 — IV 579% · EM ±48.4%Jul 14 — IV 713% · EM ±51.6%Jul 15 — IV 759% · EM ±44.8%Jul 16 — IV 1193% · EM ±49.8%Jul 20 — IV 219% · EM ±51.8%Jul 21 — IV 220% · EM ±51.1%Jul 22 — IV 124% · EM ±28.3%Jul 23 — IV 302% · EM ±68.0%Jul 24 — IV 291% · EM ±64.4%Jul 29 — IV 146% · EM ±29.2%Aug 04 — IV 74% · EM ±12.7%Aug 05 — IV 67% · EM ±11.1%Aug 06 — IV 87% · EM ±14.1%Aug 07 — IV 91% · EM ±14.3%Aug 10 — IV 205% · EM ±28.4%Aug 11 — IV 321% · EM ±42.5%Aug 12 — IV 264% · EM ±33.1%Aug 13 — IV 258% · EM ±30.5%Aug 14 — IV 168% · EM ±18.5%Aug 17 — IV 117% · EM ±9.8%Aug 19 — IV 250% · EM ±14.8%Aug 24 — IV 166% · EM ±34.7%Aug 25 — IV 162% · EM ±33.2%Aug 26 — IV 158% · EM ±31.7%Aug 27 — IV 154% · EM ±30.1%Aug 28 — IV 109% · EM ±20.9%Aug 31 — IV 121% · EM ±21.4%Sep 01 — IV 65% · EM ±11.2%Sep 02 — IV 48% · EM ±8.0%Sep 03 — IV 74% · EM ±11.9%Sep 04 — IV 76% · EM ±11.9%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in